NOXO1
Basic information
Region (hg38): 16:1978917-1984192
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NOXO1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 38 | 42 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 4 | 0 |
Variants in NOXO1
This is a list of pathogenic ClinVar variants found in the NOXO1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-1979090-A-C | not specified | Uncertain significance (Oct 05, 2021) | ||
16-1979104-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
16-1979110-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
16-1979122-C-T | not specified | Likely benign (Sep 03, 2024) | ||
16-1979128-A-C | not specified | Uncertain significance (Apr 10, 2023) | ||
16-1979144-C-T | not specified | Likely benign (Feb 16, 2023) | ||
16-1979164-A-G | not specified | Uncertain significance (Jan 30, 2024) | ||
16-1979179-G-T | not specified | Uncertain significance (Aug 02, 2022) | ||
16-1979197-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
16-1979197-G-C | not specified | Uncertain significance (Jun 29, 2022) | ||
16-1979248-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
16-1979255-C-T | not specified | Likely benign (Feb 23, 2023) | ||
16-1979291-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
16-1979333-C-T | not specified | Uncertain significance (Nov 10, 2024) | ||
16-1979457-C-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
16-1979462-C-G | not specified | Uncertain significance (Dec 02, 2022) | ||
16-1979470-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
16-1979474-C-T | not specified | Uncertain significance (May 17, 2023) | ||
16-1979497-T-A | not specified | Uncertain significance (Dec 21, 2023) | ||
16-1979501-C-T | not specified | Uncertain significance (Dec 04, 2024) | ||
16-1979519-C-T | not specified | Uncertain significance (Mar 31, 2024) | ||
16-1979521-C-T | not specified | Uncertain significance (Sep 23, 2023) | ||
16-1979531-A-T | not specified | Uncertain significance (Feb 26, 2024) | ||
16-1979819-C-A | not specified | Uncertain significance (Oct 08, 2024) | ||
16-1979837-G-T | not specified | Uncertain significance (Sep 28, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NOXO1 | protein_coding | protein_coding | ENST00000397280 | 8 | 5276 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.34e-11 | 0.0417 | 123047 | 20 | 2550 | 125617 | 0.0103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.811 | 252 | 218 | 1.15 | 0.0000127 | 2257 |
Missense in Polyphen | 84 | 67.332 | 1.2476 | 765 | ||
Synonymous | -1.31 | 115 | 98.4 | 1.17 | 0.00000568 | 842 |
Loss of Function | -0.213 | 15 | 14.1 | 1.06 | 6.90e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0116 | 0.0110 |
Ashkenazi Jewish | 0.0200 | 0.0191 |
East Asian | 0.00475 | 0.00474 |
Finnish | 0.00832 | 0.00719 |
European (Non-Finnish) | 0.0166 | 0.0149 |
Middle Eastern | 0.00475 | 0.00474 |
South Asian | 0.00226 | 0.00209 |
Other | 0.0164 | 0.0146 |
dbNSFP
Source:
- Function
- FUNCTION: Constitutively potentiates the superoxide-generating activity of NOX1 and NOX3 and is required for the biogenesis of otoconia/otolith, which are crystalline structures of the inner ear involved in the perception of gravity. Isoform 3 is more potent than isoform 1 in activating NOX3. Together with NOXA1, may also substitute to NCF1/p47phox and NCF2/p67phox in supporting the phagocyte NOX2/gp91phox superoxide-generating activity. {ECO:0000269|PubMed:12657628, ECO:0000269|PubMed:14617635, ECO:0000269|PubMed:15326186, ECO:0000269|PubMed:15824103, ECO:0000269|PubMed:15949904, ECO:0000269|PubMed:16329988, ECO:0000269|PubMed:17126813, ECO:0000269|PubMed:19755710}.;
- Pathway
- TNF alpha Signaling Pathway;Signal Transduction;RHO GTPases Activate NADPH Oxidases;RHO GTPase Effectors;Signaling by Rho GTPases;RAC1 signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.961
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.37
Haploinsufficiency Scores
- pHI
- 0.0626
- hipred
- N
- hipred_score
- 0.180
- ghis
- 0.410
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.402
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Noxo1
- Phenotype
- hearing/vestibular/ear phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- superoxide metabolic process;regulation of hydrogen peroxide metabolic process;extracellular matrix disassembly;positive regulation of catalytic activity;regulation of respiratory burst
- Cellular component
- plasma membrane;NADPH oxidase complex
- Molecular function
- protein binding;phospholipid binding;superoxide-generating NADPH oxidase activator activity;enzyme binding;phosphatidylinositol binding